• / Free eNewsletters & Magazine
  • / My Account
Home>Companies>Genzyme

Genzyme

  1. All
  2. Morningstar Articles
  3. Videos
  4. 3rd Party
  5. Investing
  1. Isis Pharmaceuticals Earns $1 Million From GSK for Advancing Hepatitis B Virus Program

    Isis Pharmaceuticals Earns $1 Million From GSK for Advancing Hepatitis B Virus Program

  2. Early Favorites for Manager of the Year--Domestic Stock

    Who's in front heading 'round the bend?

  3. REITs, Target Dates, Dollar-Proofing, and More

    A roundup of investment news.

  4. High-Confidence Stock Picks

    Focusing on stocks with the most visible cash flows has been a winning strategy, and this screen can find them.

  5. Funds Betting on Apple, Google, and RIM

    Many funds' fortunes have turned amid these stocks' volatility.

  6. Tech Stock Rally Leaves Some Funds Behind

    Plus, Vanguard says 401(k) investors stayed the course in 2008, Macquarie Group buys Delaware Investments, more leveraged ETF warnings, and more.

  7. ClearBridge Fund Prepared for Extended Rally

    The broad stock runup in the first half of 2013 was a boon to ClearBridge Aggressive Growth, and comanager Evan Bauman says that the fund is well-positioned for the market going forward.

12
Upcoming Events
Conferences
Webinars

©2014 Morningstar Advisor. All right reserved.